Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Cash from Investing (Quarterly): -0.016M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.016M |
| June 30, 2024 | -0.011M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.227M |
| September 30, 2023 | -0.065M |
| June 30, 2023 | -0.059M |
| March 31, 2023 | -0.011M |
| December 31, 2022 | 6.754M |
| September 30, 2022 | 2.069M |
| June 30, 2022 | 2.205M |
| March 31, 2022 | 43.01M |
| December 31, 2021 | 4.011M |
| September 30, 2021 | 6.291M |
| June 30, 2021 | -22.14M |
| March 31, 2021 | 10.84M |
| December 31, 2020 | -0.858M |
| Date | Value |
|---|---|
| September 30, 2020 | -24.13M |
| June 30, 2020 | 3.13M |
| March 31, 2020 | 18.27M |
| December 31, 2019 | 6.65M |
| September 30, 2019 | -2.028M |
| June 30, 2019 | 0.263M |
| March 31, 2019 | 21.07M |
| December 31, 2018 | -21.15M |
| September 30, 2018 | -58.64M |
| June 30, 2018 | -0.094M |
| March 31, 2018 | -0.017M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-24.13M
Minimum
Sep 2020
43.01M
Maximum
Mar 2022
2.786M
Average
1.034M
Median
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -16.16M |
| Elite Pharmaceuticals Inc | 0.0176M |
| Eagle Pharmaceuticals Inc | -0.006M |
| TELA Bio Inc | -0.122M |
| Terns Pharmaceuticals Inc | 31.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.558M |
| Cash from Financing (Quarterly) | -0.397M |
| Free Cash Flow | -59.62M |
| Free Cash Flow Per Share (Quarterly) | -0.1832 |
| Free Cash Flow to Equity (Quarterly) | -9.128M |
| Free Cash Flow Yield | -128.9% |